Get started
Author

Olfa Trabelsi‐Grati

Observed names: O. Trabelsi Grati, O. Trabelsi-Grati, Olfa T. Grati, Olfa Trabelsi Grati, Olfa Trabelsi-Grati, Trabelsi-Grati, Olfa
OpenAlex ID: A5031787937
Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis
2022 · Florence Oberkampf, Maya Gutierrez, et al. · Neuro-Oncology · 71
PDF
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS
2022 · Celine Callens, Francois-Clement Bidard, et al. · Analytical Chemistry · 33
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine
2024 · Célia Dupain, Tom Gutman, et al. · BMC Biology · 27
PDF
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis
2024 · Antoine Vasseur, Luc Cabel, et al. · Oncogene · 24
PDF
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets
2019 · A. Moreira, J. Masliah-Planchon, et al. · European Journal of Cancer · 20
PDF
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies
2021 · Florence Koeppel, Etienne Muller, et al. · European Journal of Cancer · 18
PDF
Microsatellite instability detection in breast cancer using drop-off droplet digital PCR
2022 · Khadidja Zeyneb Klouch, Marc-Henri Stern, et al. · Oncogene · 15
Rational testing for gene fusion in colorectal cancer: MSI and RAS-BRAF wild-type metastatic colorectal cancer as target population for systematic screening
2022 · Matthieu Delaye, Sabrina Ibadioune, et al. · European Journal of Cancer · 9
Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer
2023 · Clémence Basse, Olfa Trabelsi-Grati, et al. · International Journal of Molecular Sciences · 6
PDF
Methylation-sensitive high-resolution melting technology is a simple and sensitive method to detect germline epimutation of the MLH1 gene promoter
2025 · Hélène Delhomelle, Olfa Trabelsi-Grati, et al. · Clinical Epigenetics · 4
PDF
High prevalence of constitutional BRCA1 epimutation in patients with early-onset triple-negative breast cancer
2025 · Mathias Schwartz, Sabrina Ibadioune, et al. · Clinical Epigenetics · 4
PDF
Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report
2022 · Olfa Trabelsi Grati, Leila Zemoura, et al. · Lung Cancer · 4
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification
2024 · K. Rahmani Narj Abadi, C. Dupain, et al. · ESMO Real World Data and Digital Oncology · 3
PDF
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement
2023 · Mathias Schwartz, Sabrina Ibadioune, et al. · The Breast · 2
PDF
Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh‐frozen breast/ovarian tumor versus blood
2023 · Mathias Schwartz, Virginie Moncoutier, et al. · Clinical Genetics · 2
Abstract P5-02-19: ctDNA as dynamic marker of response to fulvestrant and everolimus in CDK4/6 inhibitor-pretreated ER+ HER2- metastatic breast cancer patients: a prospective study
2023 · Antoine Vasseur, Caroline Hego, et al. · Cancer Research · 2
APC germline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?
2022 · Roseline Vibert, Jessica Le Gall, et al. · Journal of Medical Genetics · 1
Abstract P1-07-01: Real time detection of ESR1 mutation in blood by droplet digital PCR in the PADA-1 trial: Feasibility and cross-validation with NGS
2022 · Céline Callens, François-Clément Bidard, et al. · Cancer Research · 1
Prevalence of APC Somatic Mosaicism and Colibactin Exposure in Patients With Unexplained Colorectal Adenomatous Polyposis
2026 · Bruno Buecher, Antoine Dardenne, et al. · Gastroenterology
BARD1 and breast cancer genetic predisposition: case–control study and HRD signature analysis
2026 · Marie-Florence Reveneau, Antoine De Pauw, et al. · Breast Cancer
Abstract 4070: APC mosaicism and colibactin-associated signature as key factors in unexplained colorectal polyposis
2026 · Keltouma Driouch, Zakia Tariq, et al. · Cancer Research
Bases de données de variants somatiques – SoVaD 2.0 : une nouvelle plate-forme nationale pour l’interprétation collaborative des variants somatiques rares
2026 · Walid Ben-Yedder, Céline Guien, et al. · Innovations & Thérapeutiques en Oncologie
3059eP BRCA genes reversion mutations in liquid biopsies
2025 · M. Morfouace, W. Ben Yedder, et al. · Annals of Oncology
Abstract B005: Impact of molecular profiling and ESCAT classification on patient outcome: The experience of Institut Curie Molecular Tumor Board
2023 · Maud Kamal, Kimya Rahmani Narj Abadi, et al. · Molecular Cancer Therapeutics
Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants
2021 · M.-C. Villy, J. Masliah-Planchon, et al. · Gynecologic Oncology Reports
PDF
Works count: 31
Citation count: 246
H-index: 8
I10-index: 7
Year
Topic
Type